References
- Vijayaraghavan A, Sr, Jadhav C, Pradeep B, et al. A histopathological study of endometrial biopsy samples in abnormal uterine bleeding. Cureus. 2022;14(11):e31264. doi: 10.7759/cureus.31264.
- Singh S, Best C, Dunn S, et al. No. 292-Abnormal uterine bleeding in Pre-Menopausal women. J Obstet Gynaecol Can. 2018;40(5):e391–e415. doi: 10.1016/j.jogc.2018.03.007.
- Tsakiridis I, Giouleka S, Koutsouki G, et al. Investigation and management of abnormal uterine bleeding in reproductive-aged women: a descriptive review of national and international recommendations. Eur J Contracept Reprod Health Care. 2022;27(6):504–517. doi: 10.1080/13625187.2022.2112169.
- Sabre A, Serventi L, Nuritdinova D, et al. Abnormal uterine bleeding types according to the PALM-COEIN FIGO classification in a medically underserved American community. J Turk Ger Gynecol Assoc. 2021;22(2):91–96. doi: 10.4274/jtgga.galenos.2021.2020.0228.
- Munro MG, Critchley HO, Broder MS; FIGO working group on menstrual disorders, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13. doi: 10.1016/j.ijgo.2010.11.011.
- Abbott JA. Adenomyosis and abnormal uterine bleeding (AUB-A) - pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017;40:68–81. doi: 10.1016/j.bpobgyn.2016.09.006.
- Li JJ, Chung JPW, Wang S, et al. The investigation and management of adenomyosis in women who wish to improve or preserve fertility. Biomed Res Int. 2018;2018:6832685. doi: 10.1155/2018/6832685.
- Cope AG, Ainsworth AJ, Stewart EA. Current and future medical therapies for adenomyosis. Semin Reprod Med. 2020;38(2–3):151–156. doi: 10.1055/s-0040-1719016.
- Laberge P, Leyland N, Murji A; Society of obstetricians and gynaecologists of Canada, et al. Endometrial ablation in the management of abnormal uterine bleeding. J Obstet Gynaecol Can. 2015;37(4):362–379. doi: 10.1016/s1701-2163(15)30288-7.
- McCausland V, McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update. 1998;4(4):350–359. doi: 10.1093/humupd/4.4.350.
- Vitale SG, Watrowski R, Barra F, et al. Abnormal uterine bleeding in perimenopausal women: the role of hysteroscopy and its impact on quality of life and sexuality. Diagnostics. 2022;12(5):1176. doi: 10.3390/diagnostics12051176.
- Dueholm M. Minimally invasive treatment of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2018;51:119–137. doi: 10.1016/j.bpobgyn.2018.01.016.
- Liu L, Wang T, Lei B. Image-guided thermal ablation in the management of symptomatic adenomyosis: a systematic review and meta-analysis. Int J Hyperthermia. 2021;38(1):948–962. doi: 10.1080/02656736.2021.1939443.
- Huang Y, Zhou S, Wang J, et al. Efficacy and safety of magnetic resonance-guided focused ultrasound surgery (MRgFUS) ablation in the management of abnormal uterine bleeding due to uterine leiomyoma or adenomyosis. Am J Transl Res. 2022;14(1):656–663.
- Lin XL, Hai N, Zhang J, et al. Comparison between microwave ablation and radiofrequency ablation for treating symptomatic uterine adenomyosis. Int J Hyperthermia. 2020;37(1):151–156. doi: 10.1080/02656736.2019.1708481.
- Zhang S, Wang K, Di A, et al. Ultrasound-guided percutaneous microwave ablation of adenomyosis: a narrative review. Ann Palliat Med. 2021;10(11):12003–12011. doi: 10.21037/apm-21-3133.
- Zhang HL, Yu SY, Xu HX. Ultrasound-guided microwave ablation for symptomatic adenomyosis: more areas of concern for more uniform and promising outcomes. J Interv Med. 2022;5(3):122–126. doi: 10.1016/j.jimed.2022.06.001.
- Ierardi AM, Savasi V, Angileri SA, et al. Percutaneous high frequency microwave ablation of uterine fibroids: systematic review. Biomed Res Int. 2018;2018(8):2360107. doi: 10.1155/2018/2360107.
- Li S, Li Z, Lin M, et al. Efficacy of transabdominal ultrasound-guided percutaneous microwave ablation in the treatment of symptomatic adenomyosis: a retrospective cohort study. J Minim Invasive Gynecol. 2023;30(2):137–146. doi: 10.1016/j.jmig.2022.11.004.
- Li Z, Li X, Lin M, et al. Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia. Int J Hyperthermia. 2022;39(1):1335–1343. doi: 10.1080/02656736.2022.2131001.
- Liu JX, Li JY, Zhao XY, et al. Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis: preliminary results. Int J Hyperthermia. 2019;36:1233–1238.
- Zhang HL, Yu SY, Li XL, et al. Efficacy and safety of percutaneous microwave ablation for adenomyosis in the posterior uterine wall. Br J Radiol. 2023;96:20211301. doi: 10.1259/bjr.20211301.
- Kishi Y, Suginami H, Kuramori R, et al. Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification. Am J Obstet Gynecol. 2012;207(2):114.e1–114.e7. doi: 10.1016/j.ajog.2012.06.027.
- Zhang J, Guan Z, Zhang B, et al. Clinical application guideline and recommendations of ultrasound-guided percutaneous microwave ablation in the treatment of adenomyosis. Chin J Med Ultras [in Chinese]. 2016;13:96–100. doi: 10.3877/cma.j.issn.1672-6448.2016.02.003.
- Chaudhary A, Jhaveri SJ, Sanchez A, et al. Cross-Platform ubiquitous volume rendering using programmable shaders in VTK for scientific and medical visualization. IEEE Comput Graph Appl. 2019;39(1):26–43. doi: 10.1109/MCG.2018.2880818.
- Li QY, Li XL, Deng EY, et al. Ultrasound-guided percutaneous microwave ablation for uterine fibroids: mid-term local treatment efficiency and associated influencing factors. Br J Radiol. 2022;95(1137):20220039. doi: 10.1259/bjr.20220039.
- Li JX, Li XL, Zhu JE, et al. Ultrasound-guided microwave ablation for symptomatic abdominal wall endometriosis and treatment response evaluation with contrast-enhanced imaging: the first experience. Clin Hemorheol Microcirc. 2022;82(1):63–73. doi: 10.3233/CH-211287.
- Ierardi AM, Petrillo M, Fumarola EM, et al. Percutaneous microwave ablation of uterine fibroids: correlation between shrinkage and trend symptoms. Minim Invasive Ther Allied Technol. 2021;30(1):33–39. doi: 10.1080/13645706.2019.1668417.
- Dakhly DM, Abdel Moety GA, Saber W, et al. Accuracy of hysteroscopic endomyometrial biopsy in diagnosis of adenomyosis. J Minim Invasive Gynecol. 2016;23(3):364–371. doi: 10.1016/j.jmig.2015.11.004.
- Sheth SS, Ray SS. Severe adenomyosis and CA125. J Obstet Gynaecol. 2014;34(1):79–81. doi: 10.3109/01443615.2013.832178.
- Tang Y, Ming-Tao Y, Xiang RM, et al. Preoperative CA125 as a risk factor for symptom recurrence of adenomyosis after ultrasound-guided high-intensity focused ultrasound ablation surgery. Int J Hyperthermia. 2022;39(1):1164–1169. doi: 10.1080/02656736.2022.2107716.
- Liu X, Wang W, Wang Y, et al. Clinical predictors of long-term success in ultrasound guided high-intensity focused ultrasound ablation treatment for adenomyosis: a retrospective study. Medicine (Baltimore). 2016;95(3):e2443. doi: 10.1097/MD.0000000000002443.
- Gong C, Yang B, Shi Y, et al. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: a retrospective study. Int J Hyperthermia. 2016;32(5):496–503. doi: 10.3109/02656736.2016.1149232.
- Nam JH. Pregnancy and symptomatic relief following ultrasound-guided transvaginal radiofrequency ablation in patients with adenomyosis. J Obstet Gynaecol Res. 2020;46(1):124–132. doi: 10.1111/jog.14145.
- Hai N, Zhang J, Xu R, et al. Percutaneous microwave ablation with artificial ascites for symptomatic uterine adenomyosis: initial experience. Int J Hyperthermia. 2017;33(6):646–652. doi: 10.1080/02656736.2017.1285444.
- Xu RF, Zhang J, Han ZY, et al. Variables associated with vaginal discharge after ultrasound-guided percutaneous microwave ablation for adenomyosis. Int J Hyperthermia. 2016;32(5):504–510. doi: 10.3109/02656736.2016.1150523.
- Kim YS, Kim TJ, Lim HK, et al. Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids. Eur Radiol. 2017;27(9):3956–3965. doi: 10.1007/s00330-017-4765-4.
- Van den Bosch T, Dueholm M, Leone FP, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the morphological uterus sonographic assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015;46(3):284–298. doi: 10.1002/uog.14806.
- Manasa S, Pasupula SS, Mudigonda S, et al. Endometrial ablation techniques in treating menorrhagia. Minerva Obstet Gynecol. 2023;75(3):279–287. doi: 10.23736/S2724-606X.22.05101-6.
- Daub CA, Sepmeyer JA, Hathuc V, et al. Endometrial ablation: normal imaging appearance and delayed complications. AJR Am J Roentgenol. 2015;205(4):W451–460. doi: 10.2214/AJR.14.13960.
- McCausland AM, McCausland VM. Partial rollerball endometrial ablation: a modification of total ablation to treat menorrhagia without causing complications from intrauterine adhesions. Am J Obstet Gynecol. 1999;180(6 Pt 1):1512–1521. doi: 10.1016/s0002-9378(99)70047-5.
- Bauer AM, Hackney DN, El-Nashar S, et al. Pregnancy outcomes after endometrial ablation in a multi-institutional cohort. Am J Perinatol. 2018;35(10):931–935. doi: 10.1055/s-0038-1626710.
- Lai THT, Seto MTY, Cheung VYT. Intrapartum uterine rupture following ultrasound-guided high-intensity focused ultrasound ablation of uterine fibroid and adenomyosis. Ultrasound Obstet Gynecol. 2022;60(6):816–817. doi: 10.1002/uog.24983.
- Wu S, Liu J, Jiang L, et al. Spontaneous rupture of the uterus in the third trimester after high-intensity ultrasound ablation in adenomyosis: a case report. Front Med (Lausanne). 2022;9:966620. doi: 10.3389/fmed.2022.966620.
- Hai N, Hou Q, Ding X, et al. Ultrasound-guided transcervical radiofrequency ablation for symptomatic uterine adenomyosis. Br J Radiol. 2017;90(1069):20160119. doi: 10.1259/bjr.20160119.
- Kim YJ, Kim KG, Lee SR, et al. Preoperative 3-dimensional magnetic resonance imaging of uterine myoma and endometrium before myomectomy. J Minim Invasive Gynecol. 2017;24(2):309–314. doi: 10.1016/j.jmig.2016.10.021.
- Zhang HL, Zhu JE, Li JX, et al. US-guided percutaneous microwave ablation (MWA) of the submandibular gland: a new minimally invasive and effective treatment for refractory sialorrhea and treatment response evaluation with contrast-enhanced imaging techniques. Clin Hemorheol Microcirc. 2021;78(2):215–226. doi: 10.3233/CH-211115.
- Zhang JT, Lyu GR, Qiu JC, et al. Three-dimensional ultrasound VOCAL combined with contrast-enhanced ultrasound: an alternative to contrast-enhanced magnetic resonance imaging for evaluating ablation of benign uterine lesions. Int J Hyperthermia. 2022;39(1):1360–1370. doi: 10.1080/02656736.2022.2131002.